In addition, weak, moderate and strong positive expression levels of ERCC3 were detected in 8.3% (5/60), 30% (18/60), and 61.7% (37/60) of the pancreatic cancer tissues (Figure 1A, bottom panel), and in 43.6% (24/55), 41.8% (23/55) and 14.5% (8/55) of the noncancerous pancreas tissues (Figure 1A, top panel), respectively. The gene discussed is ERCC3; the disease is pancreatic neoplasm.